Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29664W105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,043,077
- Percent of class
- 6.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-24-000435
- Form type
- SC 13G
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Nov 04, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership